These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of Inhaled Versus Deposited Dose Using the Exponential Dose-Response Model for Inhalational Anthrax in Nonhuman Primate, Rabbit, and Guinea Pig. Gutting BW; Rukhin A; Mackie RS; Marchette D; Thran B Risk Anal; 2015 May; 35(5):811-27. PubMed ID: 25545587 [TBL] [Abstract][Full Text] [Related]
6. Inhalational anthrax (Ames aerosol) in naïve and vaccinated New Zealand rabbits: characterizing the spread of bacteria from lung deposition to bacteremia. Gutting BW; Nichols TL; Channel SR; Gearhart JM; Andrews GA; Berger AE; Mackie RS; Watson BJ; Taft SC; Overheim KA; Sherwood RL Front Cell Infect Microbiol; 2012; 2():87. PubMed ID: 22919678 [TBL] [Abstract][Full Text] [Related]
7. Benchmark dose analysis for Bacillus anthracis inhalation exposures in the nonhuman primate. Taft SC; Hines SA Risk Anal; 2012 Oct; 32(10):1750-68. PubMed ID: 22469218 [TBL] [Abstract][Full Text] [Related]
8. Is there an infection risk when playing drums contaminated with Bacillus anthracis? Bennett AM; Pottage T; Parks SR J Appl Microbiol; 2016 Sep; 121(3):840-5. PubMed ID: 27348508 [TBL] [Abstract][Full Text] [Related]
9. Post-exposure therapy of inhalational anthrax in the common marmoset. Nelson M; Stagg AJ; Stevens DJ; Brown MA; Pearce PC; Simpson AJ; Lever MS Int J Antimicrob Agents; 2011 Jul; 38(1):60-4. PubMed ID: 21530184 [TBL] [Abstract][Full Text] [Related]
10. Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus). Lever MS; Stagg AJ; Nelson M; Pearce P; Stevens DJ; Scott EA; Simpson AJ; Fulop MJ Int J Exp Pathol; 2008 Jun; 89(3):171-9. PubMed ID: 18460069 [TBL] [Abstract][Full Text] [Related]
11. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001. Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664 [TBL] [Abstract][Full Text] [Related]
12. An integrated experimental-computational approach for predicting virulence in New Zealand white rabbits and humans following inhalation exposure to Bacillus anthracis spores. Hess BM; Thomas DG; Weber TJ; Hutchison JR; Straub TM; Bruckner-Lea CJ; Powell JD; Kabilan S; Corley RA PLoS One; 2019; 14(7):e0219160. PubMed ID: 31260462 [TBL] [Abstract][Full Text] [Related]
13. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Zaucha GM; Pitt LM; Estep J; Ivins BE; Friedlander AM Arch Pathol Lab Med; 1998 Nov; 122(11):982-92. PubMed ID: 9822127 [TBL] [Abstract][Full Text] [Related]
14. Transient lipopolysaccharide-induced resistance to aerosolized Bacillus anthracis in New Zealand white rabbits. Yee SB; Dyer DN; Twenhafel NA; Pitt ML Comp Med; 2013 Jun; 63(3):252-61. PubMed ID: 23759528 [TBL] [Abstract][Full Text] [Related]
15. Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment. Yee SB; Hatkin JM; Dyer DN; Orr SA; Pitt ML Comp Med; 2010 Dec; 60(6):461-8. PubMed ID: 21262133 [TBL] [Abstract][Full Text] [Related]
16. A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge. Mohamed N; Clagett M; Li J; Jones S; Pincus S; D'Alia G; Nardone L; Babin M; Spitalny G; Casey L Infect Immun; 2005 Feb; 73(2):795-802. PubMed ID: 15664918 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model. Kao LM; Bush K; Barnewall R; Estep J; Thalacker FW; Olson PH; Drusano GL; Minton N; Chien S; Hemeryck A; Kelley MF Antimicrob Agents Chemother; 2006 Nov; 50(11):3535-42. PubMed ID: 17065619 [TBL] [Abstract][Full Text] [Related]
18. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits. Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302 [TBL] [Abstract][Full Text] [Related]
19. The physiologic responses of Dutch belted rabbits infected with inhalational anthrax. Lawrence WS; Hardcastle JM; Brining DL; Weaver LE; Ponce C; Whorton EB; Peterson JW Comp Med; 2009 Jun; 59(3):257-65. PubMed ID: 19619416 [TBL] [Abstract][Full Text] [Related]
20. Pulmonary deposition of aerosolized Bacillus atrophaeus in a Swine model due to exposure from a simulated anthrax letter incident. Duncan EJ; Kournikakis B; Ho J; Hill I Inhal Toxicol; 2009 Feb; 21(2):141-52. PubMed ID: 18923948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]